PHARMACEUTICAL RDI & INVESTMENTS

Promoter – Financial Intermediary

GALENICUM HEALTH SL

Location

• Spain

Description

The project will finance the promoter's pharmaceutical RDI and expansion investments in Spain.

Objectives

The EIB loan will be used to support the implementation of the company's strategy. The investments are expected to support the promoter's competitiveness and growth.

Sector(s)

• Industry - Manufacturing

Proposed EIB finance (Approximate amount)

EUR 20 million

Total cost (Approximate amount)

EUR 50 million

Environmental aspects

All aspects related to the environmental impact and permits will be verified during the project's appraisal.

Procurement

The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having a status of a contracting entity, thus not being subject to EU rule on public procurement.

Status

Signed - 14/01/2021